World of Showjumping
Menu

This week

Coming weeks

CSI5*-W Verona
Italy

CSI4*-W Washington DC
USA

CSI3* St Lô
France

CSI3* Tryon
USA

CSI3* Montpellier
France

CSI3* Calgary, Stampede ...
Canada

CSI2* Opglabbeek
Belgium

CSI2* Michalowice
Poland

CSI2* Kronenberg
Netherlands

CSI2* Wiener-Neustadt
Austria

CSI2* Carmona
Spain

CSI2* Buenos Aires
Argentina

CSI2* Oliva Nova
Spain

FEI Tribunal lifts provisional suspensions of two jumping riders

Wednesday, 10 May 2017
Sport

The FEI Tribunal has lifted the provisional suspensions of 11 athletes – including two jumping riders: Brazil’s Marlon Modolo Zanotelli and Great Britain’s Henry Turrell.

Under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs) athletes have the opportunity to request a lifting of the provisional suspension in front of the FEI Tribunal.

Marlon Modolo Zanotelli (Sirene de la Motte, FEI ID 103RA62) and Henry Turrell (Blaze of Glory II, FEI ID 103LD21), whose horses tested positive for the banned substance sparteine after competing at separate events in Vilamoura (POR) last month, have both had their provisional suspensions lifted as of midnight CEST on 27 April. Sparteine, an antiarrhythmic used to treat cardiac arrhythmia, is found in the lupin flower, which grows in many parts of Portugal.

The FEI Tribunal’s decision to lift the provisional suspensions was mainly based on scientific evidence presented by the two athletes which suggests the likelihood of food contamination. Additionally, the FEI List Group, which reviews the FEI Equine Prohibited Substance List annually, has recommended to the FEI Bureau that Sparteine should be reclassified as a Controlled Medication and Specified Substance from 1 January 2018.

Further details on the cases can be found here. 

 


Source: Press release from FEI 

This photo has been added to your cart !

Your shopping cart »
This website is using cookies for statistics, site optimization and retargeting purposes. You consent to our cookies if you continue to use this website. Read more here.